Aura Biosciences, Inc. AURA Return on equity

Return on equity at other companies

Johnson & JohnsonJNJ

25.7%-4.5pp

Merck & Co.MRK

7%-28.5pp

IDEAYA Biosciences, Inc.IDYA

-14.3%-5.0pp

CG OncologyCGON

-26.4%+9.3pp

Arcus BiosciencesRCUS

-90.8%+373pp

LON

LeonaBio, Inc.LONA

-298.8%-726pp

FAQ

What is Aura Biosciences, Inc.'s return on equity?

Aura Biosciences, Inc. (AURA) reported return on equity of -95.6% in Q1 2026.

How has Aura Biosciences, Inc.'s return on equity changed year-over-year?

Aura Biosciences, Inc.'s return on equity decreased by 69.9% year-over-year, from -56.2% to -95.6%.

What is the long-term trend for Aura Biosciences, Inc.'s return on equity?

Over 3 years (2022 to 2025), Aura Biosciences, Inc.'s return on equity has grown at a 29.6% compound annual growth rate (CAGR), from -33.8% to -73.5%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.